Skip to main content

Table 3 Side effects/Adverse events occurring in any group and ranked by overall incidence

From: Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials

Side effects/Adverse events

Topiramate

N = 344

Placebo

N = 139

Paresthesia

71(20.64)a

4(2.88)

Upper respiratory tract infection

54(15.7)

16(9.35)

Fatigue

48(13.95)

11(7.91)

Weight decrease

39(11.34)

5(3.59)

Abdominal pain

22(6.40)

12(8.63)

Anorexia

26(7.56)

7(5.03)

Dry mouth

26(7.56)

4(2.88)

Pharyngitis

16(4.65)

13(9.35)

Memory impairment

24(6.98)

3(2.16)

Injury

16(4.65)

11(7.91)

Cognitive disorder

23(6.69)

4(2.88)

Aphasia

23(6.69)

3(2.16)

Sinusitis

14(4.07)

7(5.03)

Nausea

11(3.20)

5(3.59)

Altered mood

14(4.07)

2(1.44)

Dizziness

14(4.07)

1(0.72)

Somnolence

11(3.20)

3(2.16)

Gastroenteritis

10(2.91)

3(2.16)

Fever

10(2.91)

2(1.44)

Influenza-like symptoms

8(2.33)

2(1.44)

Sedation

4(1.16)

2(1.44)

Rhintis

5(1.45)

1(0.72)

Insomnia

4(1.16)

1(0.72)

Viral infection

4(1.16)

1(0.72)

Back pain

2(0.58)

3(2.16)

Conjunctivitis

4(1.16)

1(0.72)

Lack of concentration in school#

4(1.16)

0(0)

Coughing#

4(1.16)

0(0)

Taste perversion#

4(1.16)

0(0)

Abnorma vision

3(0.87)

1(0.72)

Eye pain

2(0.58)

2(1.44)

Vomiting

2(0.58)

1(0.72)

Nervousness#

3(0.87)

0(0)

Asthma#

2(0.58)

0(0)

Pneumonia#

2(0.58)

0(0)

Allergy#

2(0.58)

0(0)

Respiratory:bronchospasm

1(0.29)

1(0.72)

Suicide attempt#

1(0.29)

0(0)

Intussusception#

1(0.29)

0(0)

Traumatic liver injury#

1(0.29)

0(0)

  1. An individual subject might have experienced more than one side effect or adverse event
  2. aValues expressed as N (%)
  3. #Reported only in the topiramate treatment group